News

Sibling rivalry met viral internet absurdity on the latest episode of the New Heights podcast, where Jason and Travis Kelce found themselves at the center of an unexpected fan trib ...
COVID-19 tweets from November 2020 have come back to haunt Pfizer once again. | COVID-19 tweets from November 2020 have come back to haunt Pfizer once again. Fourteen months after an old tweet ...
While it no longer generates the sales it once did, Pfizer's coronavirus lineup remains critical to its results. The past three years have been challenging for Pfizer (NYSE: PFE). Although Pfizer ...
Pfizer’s Debt figure was $61 Bil at the end of the most recent quarter, while its market capitalization is $133 Bil (as of 6/2/2025). This implies a poor Debt-to-Equity Ratio of 46.2% (vs. 19.9% ...
Pfizer jumps into cancer-treatment race with a $6 billion licensing deal with a China-based company, six months after Merck’s move for a lot less money.
Pfizer isn’t stopping to smell the roses on its speed run to secure a full FDA approval for its Braftovi combination therapy. | Pfizer's Braftovi, combined with Eli Lilly's Erbitux and chemo ...
The past three years have been challenging for Pfizer (PFE 0.29%). Revenue and earnings have moved in the wrong direction, as has the company's share price. The stock is down by 56% since 2022.
Pfizer (PFE 0.40%) made a fortune thanks to its work in the COVID-19 market. In 2022, it became the first company in the biopharmaceutical industry to generate $100 billion in annual sales.
Image source: Getty Images. Pfizer: An introduction. With a recent market value near $133 billion, Pfizer is a pharmaceutical powerhouse-- tracing its roots way back to 1849 -- before the Civil ...
Pfizer (PFE) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
A colorectal cancer drug from Pfizer Inc. doubled survival time compared to the standard of care for a subset of patients, data that could change how physicians treat a particularly deadly form of ...